Lariboisière Hospital is a hospital in the 10th arrondissement of Paris, France. The hospital was one of several built following the second cholera pandemic, which had reached Paris in 1832, and which led to a new emphasis on hygienic practices in hospitals.

There are 1,333 beds in Service de Cardiologie Hopital Lariboisiere.

During the past decade, Service de Cardiologie Hopital Lariboisiere conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service de Cardiologie Hopital Lariboisiere" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "Ministry of Health, France" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Service de Cardiologie Hopital Lariboisiere" are "Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials), "Coagulation Disorder" (1 trials), "Coronary Artery Disease" (1 trials) and "Defibrillators, Implantable" (1 trials). Many other conditions were trialed in "Service de Cardiologie Hopital Lariboisiere" in a lesser frequency.

Most popular intervention types in "Service de Cardiologie Hopital Lariboisiere" are "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation of atrial fibrillation" (1 trials), "Apixaban 5 mg" (1 trials), "Azimilide Dihydrochloride" (1 trials), "Consultation with the general doctor or the cardiologist to J30 with blood results" (1 trials) and "Consultations specialized to J7 and J14" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de Cardiologie Hopital Lariboisiere" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Service de Cardiologie Hopital Lariboisiere". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Service de Cardiologie Hopital Lariboisiere, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service de Cardiologie Hopital Lariboisiere, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".